Moneycontrol

You are Here : Moving from cost to market-based pricing positive: Pfizer

Friday, 04:47

Kewal Handa, former MD, Pfizer, says that the GoM should be complimented for taking a broad view of moving from a cost-based to a market-base system.
MAR 29, 2017
09:06 AM

cnbc tv18 shows

Search
All Shows
Go

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On